Webhealth Logo

A Network Connecting Health Care Professionals
Connecting Millions Of MDs, Hospitals and Clinics

sign up

log in

Webhealth Logo
  • Home
  • HealthCare Pros
    • US Medical Doctor Directory
    • US Nurse Directory
    • Sign Up or Log In
  • HealthCare Directory
    • US Hospital Directory
    • US Clinic Directory
    • US Pharmacy Directory
    • US Lab Directory
  • Clinical Trials
    • Search by Name and Date
    • Clinical Trials By Letter
  • Videos
  • Solutions
  • About Us
  • Log-In
  • Sign-Up
Search for Clinical Trial Results

Search and View Clinical Trials by Topic

Amyloidosis - 24 Studies Found

Status Study
Not yet recruiting Study Name: Diagnostic Utility of F-18 Florbetapir PET/MR in Peripheral Nerve Amyloidosis
Condition: Amyloidosis
Date: 2017-01-03
Interventions: Other: 18-F Florbetapir PET/MR scan 18-F Florbetapir PET/MR scan, PET/MR on a GE SIGNA PET/MR scanner
Recruiting Study Name: Assessment of Minimal Residual Disease (MRD) After Antineoplastic Treatment in Patients With AL Amyloidosis
Condition: Amyloidosis
Date: 2016-03-14
Interventions: Other: blood collection Other: bone marrow
Completed Study Name: Recurrent AA Amyloidosis After Renal Transplantation
Condition: AA Amyloidosis
Date: 2016-03-04
Terminated Study Name: Idelalisib for Immunoglobulin M (IgM)-Associated Primary (AL) Amyloidosis
Condition: Amyloidosis
Date: 2015-09-09
Interventions: Drug: Idelalisib Idelalisib daily until unacceptable toxicity or disease progression.
Not yet recruiting Study Name: A Dose Escalation Study of Carfilzomib Taken With Thalidomide and Dexamethasone in Relapsed AL Amyloidosis
Condition: Amyloidosis
Date: 2015-08-27
Interventions: Drug: Carfilzomib Lyophilized
Suspended Study Name: Trial of HDM/SCT Versus HDM + Bortezomib/SCT in AL Amyloidosis
Condition: AL Amyloidosis
Date: 2015-03-09
Interventions: Drug: Bortezomib
Completed Study Name: Allo SCT in Amyloidosis Non-interventional Study
Condition: AL Amyloidosis
Date: 2014-10-02
Recruiting Study Name: Study of Chimeric Fibril-Reactive Monoclonal Antibody 11-1F4 in Patients With AL Amyloidosis
Condition: Amyloidosis
Date: 2014-09-15
Interventions: Drug: Chimeric Fibril-Reactive Monoclonal Anti-body 11-1F4 The antibody binds to the pathologic material
Completed Study Name: Bortezomib and Dexamethasone Followed by ASCT Compared With ASCT Alone in Treating Patients With AL Amyloidosis
Condition: Amyloidosis
Date: 2013-11-15
Interventions: Drug: Bortezomib Other Name: V
Active, not recruiting Study Name: Phase 1/2, Open Label, Dose Escalation Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis
Condition: Primary Amyloidosis
Date: 2012-10-11
Interventions: Drug: NEOD001 Monoclonal antibody administered by intravenous infusion every 28 days.
Page 1 of 3
Next >>>

About

  • About Us
  • Terms of Use
  • Privacy Policy
  • Opt-Out & Information Removal
  • Contact Us
  • Advertising Privacy Policy

  • Webhealth Logo

Network Sites

  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • cancerHealthCenter
  • MentalHealthHelpCenter
  • OrthopedicsHealth
  • skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • painHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter

Partner Offers

  • All Offer
  • US
  • Canadian
  • Latin America
  • European
  • Asia Pacific
  • Other

Additional

  • Advertise With Us
  • Our Brands

WebHealth Network

WebHealth Network is the leading aggregator of health, fitness, and wellness news and information from across the Web. We provide our readers with the deepest access to health information from the most trusted health publishers.

We aim to be a one stop for all the info you need to stay healthy.

Our sources include hundreds of blogs, health sites, government sites, pharmaceutical manufacturers and much more. All the information provided is publicly available and is updated daily.

Not a Substitute for Medical Advise

WebHealth Network is designed for educational purposes only. The information provided is not a substitute for professional medical advise, diagnoses, or treatment. If you are experiencing problems with your health, it is recommended that you consult a medical professional, doctor, or other health care professional. Do not delay or avoid seekeing medical advise from a professional because of any information listed on WebHealth Network. The use of the information provided on the site is at your own risk.

Ongoing medical research may change or impact the information listed on WebHealth Network. No assurances are provided that the information listed will include the most updated developments.

If you are you are experiencing a medical emergency, please call your health care professional immediately.